Advanced Wound Care Market Size, Share & COVID-19 Impact Analysis, By Product Type (Advanced Wound Dressings {Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, and Others}, Wound Care Devices {Negative Pressure Wound Therapy, Hyperbaric Oxygen Therapy, Extracorporeal Shock Wave Therapy, and Others}, and Active Wound Care {Biological Skin Equivalents, Growth Factors, Biological Dressings, and Others}), By Indication (Diabetic Foot Ulcers, Pressure Ulcers and Others), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2023-2030

The global advanced wound care market size was valued at USD 11.38 billion in 2022 and is expected to grow from USD 11.97 billion in 2023 to USD 17.48 billion by 2030, exhibiting a CAGR of 5.6% during the forecast period.

Various studies estimate that around 1% to 2% of the population in the developed countries will suffer from a chronic wound once in their lifetime. Besides, developing countries present a large pool of patients suffering from chronic wounds such as diabetic foot ulcers and pressure ulcers, among others. The rising number of patients undergoing surgeries globally has led to the surge in the patient population suffering from surgical wounds. A chronic wound can be classified as one that fails to progress through the phases of healing in an orderly and timely sequence and shows no significant improvement in 30 days.

In contrast, acute wounds heal through the routine process of inflammation, tissue formation, and remodeling in a short duration. The wound care products such as NPWT, skin grafts, and substitutes are designed exclusively to treat chronic and acute wounds.

The rising prevalence of chronic diseases, such as diabetes, limited mobility, vascular conditions, and others, increases patients' risk of developing chronic wounds. Among all wound types, diabetic foot ulcer is one of the most common types of chronic wounds affecting people across the globe. Moreover, the rising number of traumas, accidents, and surgeries leads to acute wounds. Thus, the increasing cases of chronic and acute wounds surge the demand for these products, propelling the global advanced wound care market growth in the forthcoming years.

According to an NCBI article published in 2021, approximately 310 million surgeries are performed each year across the globe. Out of these, about 40-50 million surgeries are performed in the U.S. and about 20 million in Europe.

Thus, rising surgical procedures, along with various other factors, are anticipated to propel market growth.

COVID-19 IMPACT

Pandemic Period Recorded Decline in Demand for Advanced Wound Care Products Owing to Cancellation of Non-emergency Surgical Procedures

The impact of the COVID-19 pandemic on certain medical device segments is expected to be more pronounced due to the slowdown in non-emergency procedures and healthcare services. More than 2 million non-emergency procedures were canceled in the U.K. to free up healthcare resources to fight against the pandemic. Similarly, hospitals in the U.S. saw a 30-60% decline in hospital visits after the announcement of coronavirus as a pandemic in 2020.

Countries globally had reallocated healthcare resources, such as hospital beds, nurses, essential personnel, and medical devices, to manage COVID-19 patients. This has resulted in the exemption of wound care from the essential procedures list and implementation in the elective procedures list in most countries. Healthcare facilities, including specialized wound care clinics and hospitals with dedicated advanced wound care departments, were closed with the number of beds available in these settings as they are utilized for COVID-19 patients. This has significantly impacted the number of patient visits to wound centers and outpatient departments, especially in the U.S. and European countries.

• According to statistics published by Tissue Analytics, Inc., there was an estimated 40% drop in patient visits in wound centers during March and April 2020, as compared to 2019.

However, the market regained normalcy in the post-pandemic period due to the resumption of various surgeries, increase in patient visits, and rising demand for these products. Additionally, the key manufacturers operating also witnessed an increase in their revenues in 2021 as compared to 2020.

• For instance, in 2021, Integra LifeSciences observed 34% increase in revenue generation from the wound reconstruction and care segment.

LATEST TRENDS

Request a Free sample to learn more about this report.

Shifting Focus to Introduce Active Therapies for Wound Management 

Currently, patients across the globe are seeking urgent and effective treatment for chronic wounds comprising pressure ulcers, diabetic foot ulcers, and venous ulcers, among others. Active wound care products, including biological skin equivalents and growth factors have an established and clinically proven efficiency in the treatment of hard-to-heal chronic wounds. To cater to the rising demand, the key players are shifting their focus to introduce novel bioactives in the market. For instance:

• In July 2022, Tides Medical, a biologics company, launched a tri-layer skin graft, “Artacent”, for treating complex or difficult-to-treat wounds.


• In February 2021, Axio Biosolutions received a CE mark for an advanced wound dressing, MaxioCel, based on bioactive microfiber gelling for an accelerated wound healing process.

Thus, the launch and approval of next-generation active wound care products by various players have been instrumental in boosting the adoption of skin grafts, collagen dressings, and other active therapies. This factor is anticipated to support the growth of the market during the advanced wound care market forecast period.

DRIVING FACTORS

Rising Prevalence of Chronic and Acute Wounds to Fuel Demand for Dressings and Devices

The increasing prevalence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and acute wounds, including surgical, and traumatic wounds globally, is expected to increase the number of patients undergoing treatment for chronic wounds. Moreover, the increasing burden of chronic disorders among the old-age population and the rising number of accidents are the major factors leading to an increase in the population suffering from various wounds, aiding the market growth.

According to the World Health Organization (WHO) 2022 report, the number of people over 60 years old will increase from 1 billion in 2020 to 2.1 billion by 2050. 

• Additionally, as per WHO 2022, 20 million – 50 million people suffer from non-fatal injuries due to road crash traffic.

Also, the launch of technologically advanced products with better wound healing properties compared to traditional wound care products is expected to bolster the market growth.

• For instance, in August 2022, 3M made some advancements in 3M Veraflo Therapy (negative pressure wound therapy system with instillation) for faster, easier, less painful dressings.

RESTRAINING FACTORS

High Cost Associated with Devices and Active Therapies to Limit their Adoption 

Despite higher prevalence of chronic and acute wounds globally, certain factors are limiting the market growth. Among them is the high cost associated with advanced wound products and limited reimbursement for these products in emerging countries. According to an economic analysis between wound dressings and NPWT, the average cost of NPWT pumps in the U.S. is around USD 90, while that of wound dressing is around USD 3.

Although various studies have demonstrated that the overall cost of treatment by wound dressings is comparatively higher (estimated at USD 350) than NWPT (estimated at USD 200) per person, these costs are higher when compared to traditional wound dressings. The cost of treatment is higher for advanced wound care devices, including negative pressure wound therapy and skin grafts, and the cost escalates as the wound progresses from acute to chronic.

Additionally, the lack of adequate reimbursement policies, especially in emerging countries, has limited the adoption of products and devices. A significant proportion of the overall cost of treatment in emerging countries is out-of-pocket cost, which further limits the uptake of advanced wound dressings and devices for treating chronic wounds. Considering the above factors, people in these regions prefer traditional wound care products to advanced ones.

SEGMENTATION

By Product Type Analysis

To know how our report can help streamline your business, Speak to Analyst

High Efficiency and Lower Cost to Propel Advanced Wound Dressings Demand

Based on product type, the market is segmented into advanced wound dressings, wound care devices, and active wound care. The advanced wound dressings segment dominated the market share in 2022. The lower cost of wound dressings and its high efficiency in exudate management of wounds are expected to boost its adoption. Further, the launch of new advanced wound dressing products with enhanced properties is projected to contribute to the market growth.

• For instance, in January 2023, ConvaTec Group PLC launched ConvaFoam in the U.S. The product is an advanced foam dressing with improved absorbed fluid handling, improved adhesion, and a superabsorbent layer for difficult-to-treat wounds.

The active wound care segment is likely to register a substantial CAGR during the forecast period due to increasing applications of active therapies, such as skin grafts and biologics, for treating hard-to-heal chronic wounds. The benefits associated with active dressings, such as prevention of heat loss, protein and electrolyte loss, and permitting autolytic debridement, among others are contributing to market growth. An additional factor includes increase in research & development to introduce various active wound care products.

However, the wound care devices segment is expected to grow at a significant CAGR during the forecast period due to the increasing number of market players engaged in introducing advanced devices such as single-use NPWT in the global market.

By Indication Analysis

Diabetic Foot Ulcers Segment Dominated the Market Owing to Higher Prevalence and High Cost of Treatment

On the basis of indication, the market is categorized into diabetic foot ulcers, pressure ulcers, surgical wounds, and others. The diabetic foot ulcers segment dominated the market owing to the rising prevalence of diabetes across the globe. According to various research, patients suffering from uncontrolled diabetes are at a higher risk of developing diabetic foot ulcers, further contributing to the rising demand for advanced wound care products among these patients.

• According to the International Diabetes Federation 2021 published statistics, an estimated 571 million were living with diabetes globally, which is expected to increase to 643 million and 783 million by 2030 and 2045, respectively.


• Further, as per an article published by NCBI in 2022, the prevalence of diabetic foot ulcer is approximately 6.3% across the globe.

The surgical wounds segment is anticipated to project a significant CAGR during the forecast period owing to the increase in the number of surgical procedures coupled with the increasing incidences of surgical site infections (SSI) among patients.

By End User Analysis

Rising Number of Admissions to Propel Hospitals Segment Growth

In terms of end user, the market is segmented into hospitals, clinics, homecare settings, and others. The hospitals segment held a dominant market share and is anticipated to continue its dominance. The dominance is due to increased hospital admissions of patients suffering from acute or chronic wounds. The clinics segment is expected to exhibit a remarkable CAGR during the forecast period due to increasing stand-alone clinics in emerging and developed countries.

Furthermore, the homecare settings segment may register substantial growth by the end of the forecast period owing to the rising preference shift of patients from hospital to homecare settings.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

The market size in North America stood at USD 4.79 billion in 2022. Rising prevalence of acute and chronic wounds and higher treatment costs associated with pressure ulcers, diabetic foot ulcers, and surgical wounds is expected to boost adoption. For instance, according to the Agency for Healthcare Research and Quality estimations, the total medical cost for managing pressure ulcers in the U.S. ranged from USD 9.1 to USD 11.6 billion per year. Furthermore, adequate reimbursement policies in the U.S. and Canada are responsible for North America’s dominance in the market.

The Europe market is expected to grow at a significant CAGR over the forecast period. This is due to rising awareness regarding the availability of treatment for chronic wounds and the surging demand for these products.

• For instance, in February 2021, Axio Biosolutions received CE mark for its advanced wound care product MaxioCel. The solution is based on bioactive microfiber gelling technology for an accelerated wound healing process for chronic wounds such as pressure ulcers, diabetic foot ulcers, and others.

The Asia Pacific market is expected to exhibit healthy growth over the estimated period. This is on account of increasing per capita healthcare spending. In addition, market players in this region make heavy investments, which, in turn, will fuel the demand for advanced products for wound management. Furthermore, rising government initiatives to raise awareness for proper wound management are also expected to raise the adoption of these products.

• For instance, Wound Australia allocated a fund of USD 1.5 million in the 2022-23 Pre-Budget Submissions to create awareness regarding chronic wound prevention and treatment through national media and digital campaigns.

The Latin America and the Middle East & Africa markets accounted for a comparatively lower advanced wound care market share due to their underpenetrated markets. However, the increase in cases of acute and chronic wounds due to trauma, chronic illness, and accidents and rising market players’ efforts to expand their geographical reach in the regions are a few factors contributing to the market growth in the coming years.

To know how our report can help streamline your business, Speak to Analyst

• In May 2021, Sanuwave Health, Inc., a provider of next generation wound care products, and its partners signed a distribution agreement with Grupo Suprimed to sell the dermaPace system in Brazil.

KEY INDUSTRY PLAYERS

3M, Smith & Nephew, and ConvaTec to Lead the Market Owing to Strong Product Portfolio 

The market is consolidated due to a strong product portfolio and remarkable distribution networks of major companies in emerging and developed countries. Smith & Nephew, ConvaTec, Inc., and 3M lead the market, accounting for a dominant revenue share in 2022.

However, the lack of strong barriers to entry may lead to a rising entry of domestic players in the worldwide market. This factor is expected to lead to a slightly fragmented market by the end of 2030.

• For instance, in July 2021, PolarityTE, Inc. announced the submission of an investigational new drug application (IND) to the U.S. FDA to seek authorization to initiate clinical trials for the SkinTE product in the treatment of chronic cutaneous ulcers.

Other key players include Integra Life Sciences, MiMedx, Coloplast Corp, Derma Sciences Inc., Tissue Regenix, Mölnlycke Health Care AB, and Organogenesis Inc., which also entered the market with advanced wound care products. The introduction of innovative products, such as NPWT and advanced wound dressings, and significant investments in developing bioactive therapies for treatment are some of the major strategies enabling companies to boost their market position.

• For instance, in January 2021, Integra LifeSciences acquired ACell, Inc. to expand its advantage wound care product portfolio. Also, through this acquisition, the company aimed to offer more comprehensive wound management solutions to its customers.

LIST OF KEY COMPANIES PROFILED:

• Smith & Nephew (U.K.)


• 3M (U.S.)


• MiMedx (Georgia)


• Coloplast Corp (Denmark)


• ConvaTec Inc. (U.K.)


• Tissue Regenix (U.S.)


• Derma Sciences Inc. (U.S.)


• Mölnlycke Health Care AB (Sweden)


• Organogenesis Inc. (U.S.)


• Integra LifeSciences (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• November 2022 – Reddress Medical, a U.S. and Israel-based private wound care company, made its advanced wound care management system, ActiGraft+ system, commercially available in Puerto Rico.


• October 2022 – Healthium Medtech Limited launched Theruptor Novo, an advanced wound care product for the treatment of leg ulcers and diabetic foot ulcers.


• May 2022 – Winner Medical launched its advanced wound care products, including CMC dressings in France.


• August 2021 – MiMedx, one of the prominent players in the market, established a subsidiary in Tokyo, Japan to expand its geographical presence.


• May 2021 – Activheal launched a prescription dispensing service, ActiveCare Direct, for easy access to a comprehensive range of advanced wound dressings.

REPORT COVERAGE

An Infographic Representation of Advanced Wound Care Market

View Full Infographic

To get information on various segments, share your queries with us

The global market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, competitive landscape, products, applications, and end users. Besides this, it offers insights of the trends and highlights key industry developments. In addition to the factors mentioned above, the report encompasses several factors that have contributed to the growth of the market in recent years.

Report Scope & Segmentation